mRNA |
paclitaxel |
CTRPv2 |
pan-cancer |
AAC |
0.061 |
0.06 |
mRNA |
I-BET151 |
CTRPv2 |
pan-cancer |
AAC |
-0.056 |
0.06 |
mRNA |
Cerulenin |
CTRPv2 |
pan-cancer |
AAC |
-0.06 |
0.06 |
mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.065 |
0.07 |
mRNA |
Crizotinib |
gCSI |
pan-cancer |
AAC |
0.11 |
0.07 |
mRNA |
Vandetanib |
CCLE |
pan-cancer |
AAC |
-0.087 |
0.07 |
mRNA |
ETP-46464 |
CTRPv2 |
pan-cancer |
AAC |
-0.075 |
0.07 |
mRNA |
BRD-K24690302 |
CTRPv2 |
pan-cancer |
AAC |
-0.065 |
0.07 |
mRNA |
ML210 |
CTRPv2 |
pan-cancer |
AAC |
-0.058 |
0.07 |
mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.05 |
0.07 |